Skip to content

Member

Ewa KOPACZ

EPP · Poland

Group
EPP PPE
Country
Poland
Roll-call participation
98.7 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
91.6 %ⓘ of 5 853 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
KO Koalicja Obywatelska
In office
Since 16 Jul 2024
Against clear line
336 of 5 571 votesⓘ
Committees
ENVI, FEMM, SANT (substitute)
Member id
197525
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

98.7 %

5 853 of 5 928 roll calls while in office

EPP median: 89.9 % (+8.8 pts)

Chamber median: 90.2 %

With majority line ⓘ

91.6 %

5 364 of 5 853 votes where their group had a line

EPP median: 93.6 % (−2.0 pts)

Against clear line ⓘ

6.0 %

336 of 5 571 votes where their group had a clear line

267 opposite (for ↔ against), 68 abstained against the line, 1 voted for or against when the line was to abstain

Abstention ⓘ

1.9 %

109 of 5 853 votes cast

Participation 98.7 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
Ewa KOPACZ98.7 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 91.6 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
Ewa KOPACZ91.6 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: Abstained Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: For Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: Abstained Majority line: Abstained
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: Against Majority line: Against
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 6 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202422
18 Sept 202422
19 Sept 20249291
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202420
22 Oct 20241010
23 Oct 2024129129
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202422
26 Nov 20241818
27 Nov 20241111
28 Nov 20245756
17 Dec 20241313
18 Dec 20243333
19 Dec 20244545
20 Jan 202522
21 Jan 202511
22 Jan 202521
23 Jan 20254541
10 Feb 202510
11 Feb 20253232
12 Feb 20251010
13 Feb 20253029
10 Mar 202522
11 Mar 202599
12 Mar 2025228225
13 Mar 20252423
31 Mar 202533
1 Apr 20253535
2 Apr 2025251248
3 Apr 20256261
5 May 202554
6 May 20251010
7 May 2025220220
8 May 2025103103
21 May 202522
22 May 20255352
16 Jun 202522
17 Jun 20254141
18 Jun 20259191
19 Jun 20258787
7 Jul 202511
8 Jul 20255555
9 Jul 2025134134
10 Jul 20253636
8 Sept 202511
9 Sept 2025101101
10 Sept 20253434
11 Sept 20256969
6 Oct 202522
7 Oct 202555
8 Oct 20255555
9 Oct 20256565
20 Oct 202533
21 Oct 20251313
22 Oct 2025186186
23 Oct 20255555
13 Nov 2025267267
24 Nov 202533
25 Nov 20257575
26 Nov 2025100100
27 Nov 2025125125
15 Dec 202544
16 Dec 20256666
17 Dec 20254343
18 Dec 20254242
20 Jan 20266767
21 Jan 2026112112
22 Jan 20265858
9 Feb 202622
10 Feb 20263838
11 Feb 20261313
12 Feb 2026141141
24 Feb 2026430
9 Mar 202611
10 Mar 2026197197
11 Mar 20266060
12 Mar 20263434
25 Mar 202633
26 Mar 20266969
27 Apr 202620
28 Apr 2026225224
29 Apr 2026296295
30 Apr 20266868
18 May 202640
19 May 202633
20 May 20269696
21 May 20269898
15 Jun 202622
16 Jun 20264040
17 Jun 2026127126
18 Jun 20267777
6 Jul 202620
7 Jul 20267272
8 Jul 2026144144
9 Jul 20266767
14 Sept 202611
15 Sept 2026155155
16 Sept 20268080
17 Sept 2026124124

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Mirosława NYKIEL EPPPoland98 % of 5 236 shared89 %
Andrzej BUŁA EPPPoland98 % of 5 367 shared89 %
Krzysztof BREJZA EPPPoland98 % of 5 431 shared89 %
Jagna MARCZUŁAJTIS-WALCZAK EPPPoland98 % of 5 484 shared89 %
Dariusz JOŃSKI EPPPoland97 % of 5 731 shared89 %
Andrzej HALICKI EPPPoland97 % of 5 335 shared89 %
Michał WAWRYKIEWICZ EPPPoland97 % of 5 330 shared89 %
Bartosz ARŁUKOWICZ EPPPoland97 % of 5 594 shared89 %
Magdalena ADAMOWICZ EPPPoland97 % of 5 501 shared89 %
Elżbieta Katarzyna ŁUKACIJEWSKA EPPPoland97 % of 5 573 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Urmas PAET RenewEstonia84 % of 5 292 shared82 %
Dan BARNA RenewRomania84 % of 5 142 shared82 %
Sophie WILMÈS RenewBelgium84 % of 4 038 shared82 %
Hilde VAUTMANS RenewBelgium84 % of 5 672 shared82 %
Eugen TOMAC RenewRomania83 % of 4 237 shared82 %
Ivars IJABS RenewLatvia83 % of 4 485 shared82 %
Katri KULMUNI RenewFinland83 % of 4 625 shared82 %
Dan NICA S&DRomania83 % of 3 531 shared75 %
Benoit CASSART RenewBelgium83 % of 5 360 shared82 %
Dainius ŽALIMAS RenewLithuania83 % of 5 454 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Women’s Rights and Gender EqualityFEMM CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with CanadaD-CA DelegationMember19 Sept 2024now
Delegation for Northern cooperation and for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary CommitteeDEEA DelegationSubstitute19 Sept 2024now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeSubstitute19 Jul 202419 Jan 2025

Show all 7 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteur for an opinionENVI10 Apr 2026
Impact of social media and the online environment on young peopleShadow rapporteur for an opinionFEMM26 Sept 2025
No dossier namedVice-President9 Jul 2024

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

194 contributions recorded, 12 written statements; 4 on behalf of their group; 65 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
16 Sept 2026Approval of the minutes of the sitting SpeechRead
16 Sept 2026Agenda of the next sitting SpeechRead
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure (A10-0212/2026 - Rasa Juknevičienė) SpeechRead
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure (A10-0212/2026 - Rasa Juknevičienė) SpeechRead
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) (A10-0273/2025 - Sven Mikser, Pierfrancesco Maran, Aura Salla) SpeechRead
16 Sept 2026Acceleration of permit-granting for defence readiness projects (Omnibus V) (A10-0271/2025 - Lucia Yar, Henrik Dahl) SpeechRead
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) (A10-0273/2025 - Sven Mikser, Pierfrancesco Maran, Aura Salla) Speech · 1 minRead
16 Sept 2026Oral explanations of votes (Rule 201) SpeechRead
16 Sept 2026Devastating floods in Nepal (debate) SpeechRead
16 Sept 2026Devastating floods in Nepal (debate) Speech · 1 minRead

Show all 40 recent contributions

Questions and motions, 25

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
10 Sept 2026Sexual exploitation of children in travel and tourism: closing the gaps beyond the EU’s borders E-10-2026-003633Written questionwith 11 co-authorsNot yet answered
13 Jul 2026Missing and runaway children as an indicator of violence, abuse and grooming E-10-2026-002868Written questionwith 15 co-authorsNot yet answered
29 Jun 2026Protecting minors online from manipulation, bullying and grooming E-10-2026-002680Written questionwith 9 co-authors11 Sept 2026
17 Jun 2026Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516Written questionwith 17 co-authors24 Aug 2026
9 Jun 2026Chinese tomato concentrate imports: protecting EU producers and food security P-10-2026-002375Priority written questionwith 23 co-authors13 Jul 2026
6 May 2026Continuity of tertiary education for pregnant women and women with children E-10-2026-001857Written questionwith 46 co-authors3 Jul 2026
27 Apr 2026MOTION FOR A RESOLUTION on the need for targeted criminal provisions and platforms’ responsibility to effectively address cyberbullying and online harassment B-10-2026-0235Motion for a resolutionwith 11 co-authors—
17 Apr 2026The need for targeted criminal provisions on cyberbullying and online harassment and platforms’ responsibility to effectively address these issues O-10-2026-000018Oral questionwith 11 co-authorsNot yet answered
11 Mar 2026Financing EU priorities in a sustainable, predictable and resilient way through a new EU own resource from the online gambling and betting services sector O-10-2026-000014Oral questionwith 42 co-authorsNot yet answered
24 Feb 2026Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762Written questionwith 20 co-authors16 Apr 2026

Show all 25 questions and motions

Amendments tabled in committee, 41

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ531
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ536
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ5314
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5321
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ538
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ532
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ535
26 Jun 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) ENVI-AM-790222 ENVI16

Show all 41 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Poland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Ewa KOPACZ”. Member record. memberId 197525. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197525?page=4&scope=all&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197525. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197525?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197525,
  author = {{EU Parl Watch Research}},
  title = {{Ewa KOPACZ}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197525?page=4&scope=all&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/197525?page=4&scope=all&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197525. Official source: https://www.europarl.europa.eu/meps/en/197525. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}